Checkpoint Inhibitor Immune-Related AE (Colitis) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Checkpoint Inhibitor Immune-Related AE (Colitis)
Checkpoint inhibitor immune-related adverse event (irAE) colitis is a serious inflammation of the colon that can occur during certain cancer treatments. While effective against cancer, these therapies can sometimes cause the immune system to attack healthy tissues. Managing irAE colitis often requires costly medications, but TheDrugClub helps members afford essential prescriptions, easing the financial burden during a challenging time.
Checkpoint inhibitors are a revolutionary class of cancer drugs that unleash the body's immune system to fight tumors. While incredibly effective, they can sometimes cause the immune system to mistakenly attack healthy organs, leading to what are known as immune-related adverse events (irAEs). One such serious irAE is colitis, an inflammation of the colon. This condition can manifest with symptoms like severe diarrhea, abdominal pain, and blood in the stool, requiring prompt medical attention and often temporary discontinuation of cancer therapy.
Treating checkpoint inhibitor-induced
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
Related conditions
- Checkpoint Inhibitor irAE (Arthritis)
- Checkpoint Inhibitor irAE (Endocrinopathy)
- Checkpoint Inhibitor irAE (Hepatitis)
- Checkpoint Inhibitor irAE Management
- Checkpoint Inhibitor irAE (Myocarditis)
- Checkpoint Inhibitor irAE (Nephritis)
- Checkpoint Inhibitor irAE (Neuropathy)
- Checkpoint Inhibitor irAE (Pneumonitis)